Business / Finance

RSS

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Ember Therapeutics, Inc., a Boston-based biotechnology company dedicated to the discovery and development of novel obesity and diabetic related therapies, and Mariel Therapeutics, a privately held, New York-based biotechnology company developing targeted therapies for osteoarthritis and kidney fibrosis using Bone Morphogenetic Protein (BMP)-7, jointly announce today that they have entered into a definitive agreement to merge the two companies.

12 Mar 2015

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of a definitive licensing and development agreement with MultiCell Immunotherapeutics, Inc. concerning the development of certain antibody-drug conjugates (ADCs).

12 Mar 2015

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

Norgine and Arc Medical Design Ltd. today announced a partnership that will see Norgine commercialising and distributing ENDOCUFF VISION, a Class 1 sterile medical device used in colonoscopy, across a number of major European markets, Australia and New Zealand. Norgine's first launch of ENDOCUFF VISION will take place in the UK Q2 2015.

12 Mar 2015

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

Sigma-Aldrich Corporation today announced that SAFC Commercial, its custom manufacturing services business unit, has entered a commercial sales and service contract with leading biopharmaceutical company, BeiGene.

11 Mar 2015

Green Cross makes investment in cell therapy sector in China

Green Cross, a South Korean biopharmaceutical company, today announced that it had signed MOU on the 6th of March with the Guizhou provincial government of China for the investment in the cell therapy sector in China.

11 Mar 2015

Chromogenex US, LiLa sign distribution agreement for i-lipo and i-lipo Ultra body sculpting systems

Chromogenex US, Inc., of Howell, Michigan, the sister company of Chromogenex Technologies, Ltd., and LiLa Enterprise, LLC of Suwanee, Georgia, announced today a strategic alliance wherein Chromogenex US appoints LiLa the exclusive distributor for the i- lipo and i-lipo Ultra body sculpting systems that employ low level laser technology for smoothing cellulite, fat reduction and body shaping treatments.

11 Mar 2015

USAP, Pinnacle announce new partnership with Excel Anesthesia

U.S. Anesthesia Partners, the nation's largest anesthesia-focused, single-specialty physician services organization, and Pinnacle Anesthesia Consultants of Dallas, Texas today announced their partnership with Excel Anesthesia, P.A.

11 Mar 2015

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

OWC Pharmaceutical Research Corp.'s wholly owned subsidiary One World Cannabis Ltd. signed a collaboration agreement with Sheba Academic Medical Center, the largest hospital in Israel and in the Middle East.

11 Mar 2015

MDC scientists identify new molecular signaling pathway that regulates placental development

During pregnancy, the mother supplies the fetus with nutrients and oxygen via the placenta. If placental development is impaired, this may lead to growth disorders of the embryo or to life-threatening diseases of the mother such as preeclampsia, a serious condition involving high blood pressure and increased urinary protein excretion.

11 Mar 2015

InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

InMed Pharmaceuticals Inc. announces it has formed an exclusive strategic collaboration with the University of Debrecen, Hungary, to develop novel phytocannabinoid-based therapies to treat ocular allergic symptoms.

10 Mar 2015

Impax Laboratories acquires Tower Holdings and Lineage Therapeutics

Impax Laboratories, Inc. today announced that it has completed its acquisition of Tower Holdings, Inc. (including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC), and Lineage Therapeutics Inc. (together, the "Companies").

10 Mar 2015

VENITI closes $17 million in equity and debt financing

VENITI, Inc., a St. Louis, MO-based medical device company is pleased to announce that it has closed on an equity and debt financing totaling over $17 million. The equity portion, its Series C, was led by previous investors, Baird Capital and Tekla Healthcare and Tekla Life Science Investors, with strong internal participation.

10 Mar 2015

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc. is using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product candidate MM-121.

From Advanced Cell Diagnostics 9 Mar 2015

BioTools unveils revolutionary family of portable raman microscopes

BioTool’s revolutionary new family of portable Raman microscopes bridges the gap between microscopy and spectroscopy, bringing microRaman out of the lab and into the world at large, opening new opportunities for doing the same analyses in different locations with the same instrumentation.

9 Mar 2015

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

Integrated DNA Technologies (IDT) has pooled its expertise in genome editing into a free web resource dedicated to providing researchers a hub of information on the very latest in using the CRISPR/Cas9 system.

From Integrated DNA Technologies 9 Mar 2015

Particle Sciences to expand sterile manufacturing for complex products and particulates

Particle Sciences, Inc (PSI), the leading CDMO for micro and nano-particulates is expanding its sterile and aseptic manufacturing capacity generally and specifically for nano-milled drug products.

9 Mar 2015

G-treeBNT to receive $7.28 million to expand international development of RGN-259/GBT-201

RegeneRx Biopharmaceuticals, Inc. has been notified that its joint venture partner and licensee, G-treeBNT Co. Ltd., will receive $7.28 million USD to expand international development of its product candidate, RGN-259 (designated GBT-201).

9 Mar 2015

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

9 Mar 2015

EMD Serono executes amendment agreement with Opexa for development of Tcelna (imilecleucel-T)

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced today the execution of an amendment to its agreement with Opexa Therapeutics, Inc. for the development and commercialization of its investigational compound Tcelna (imilecleucel-T).

9 Mar 2015

Carter Validus Mission Critical REIT II buys Heartland Rehabilitation Hospital property from Medistar

Medistar Corporation announced that it has sold the Heartland Rehabilitation Hospital property to Carter Validus Mission Critical REIT II, Inc. on February 17th 2015. The rehabilitation hospital is located in Overland Park, Kansas.

5 Mar 2015

Business / Finance

Ember Therapeutics, Mariel Therapeutics sign definitive merger agreement

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Norgine partners with Arc Medical to commercialize and distribute ENDOCUFF VISION

BeiGene chooses SAFC's CHOZN Platform to support oncology drug development

Green Cross makes investment in cell therapy sector in China

Chromogenex US, LiLa sign distribution agreement for i-lipo and i-lipo Ultra body sculpting systems

USAP, Pinnacle announce new partnership with Excel Anesthesia

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

MDC scientists identify new molecular signaling pathway that regulates placental development

InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

Impax Laboratories acquires Tower Holdings and Lineage Therapeutics

VENITI closes $17 million in equity and debt financing

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

BioTools unveils revolutionary family of portable raman microscopes

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

Particle Sciences to expand sterile manufacturing for complex products and particulates

G-treeBNT to receive $7.28 million to expand international development of RGN-259/GBT-201

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

EMD Serono executes amendment agreement with Opexa for development of Tcelna (imilecleucel-T)

Carter Validus Mission Critical REIT II buys Heartland Rehabilitation Hospital property from Medistar

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News